All Outputs (2)

Short-term oral administration of the Porcupine inhibitor, Wnt-c59, improves the structural and functional features of experimental HFpEF. (2025)
Journal Article
WALSH, S.K. [2025]. Short-term oral administration of the Porcupine inhibitor, Wnt-c59, improves the structural and functional features of experimental HFpEF. Pharmacology research and perspectives [online], (accepted).

Heart failure with preserved ejection fraction (HFpEF) accounts for approximately 50% of heart failure cases globally, and this incidence is increasing due to extended lifespans and accumulating comorbidities. Emerging evidence suggests that Wnt sign... Read More about Short-term oral administration of the Porcupine inhibitor, Wnt-c59, improves the structural and functional features of experimental HFpEF..

Exploring the role of Wnt signalling in heart failure with preserved ejection fraction. (2022)
Thesis
PAUL, M.A. 2022. Exploring the role of Wnt signalling in heart failure with preserved ejection fraction. Robert Gordon University, PhD thesis. Hosted on OpenAIR [online]. Available from: https://doi.org/10.48526/rgu-wt-1987960

According to the European Society of Cardiology long-term out-patient registry, heart failure with preserved ejection fraction (HFpEF) accounts for approximately 16% of heart failure cases, with survival rates failing to improve due to the lack of ef... Read More about Exploring the role of Wnt signalling in heart failure with preserved ejection fraction..